KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Total Current Liabilities (2016 - 2025)

Rigel Pharmaceuticals has reported Total Current Liabilities over the past 16 years, most recently at $99.2 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 56.77% year-over-year to $99.2 million; the TTM value through Dec 2025 reached $99.2 million, up 56.77%, while the annual FY2025 figure was $99.2 million, 56.77% up from the prior year.
  • Total Current Liabilities for Q4 2025 was $99.2 million at Rigel Pharmaceuticals, up from $94.4 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $99.2 million in Q4 2025 and troughed at $44.0 million in Q2 2023.
  • A 5-year average of $62.4 million and a median of $59.3 million in 2021 define the central range for Total Current Liabilities.
  • Biggest five-year swings in Total Current Liabilities: decreased 23.14% in 2023 and later skyrocketed 73.81% in 2025.
  • Year by year, Total Current Liabilities stood at $63.6 million in 2021, then rose by 2.61% to $65.2 million in 2022, then dropped by 18.32% to $53.3 million in 2023, then rose by 18.83% to $63.3 million in 2024, then soared by 56.77% to $99.2 million in 2025.
  • Business Quant data shows Total Current Liabilities for RIGL at $99.2 million in Q4 2025, $94.4 million in Q3 2025, and $86.6 million in Q2 2025.